AI Impact on Global Cell and Gene Therapy Tools and Reagents Market - BCC Pulse Report

Report Highlights

This report provides a brief overview of AI impact on the global cell and gene therapy (CGT) tools and reagents market. It highlights major adoption trends across the key geographic regions, and disruptions caused across several key industry verticals.

Report Includes

• Impact analysis of artificial intelligence (AI) on the global market for cell and gene therapy (CGT) tools and reagents
• Case studies for successful integration of AI and automation in accelerated drug discovery, optimized clinical trials and personalized treatments
• Highlights of AI adoption trends across the major geographical regions as well as disruptions caused by AI across key industry verticals
• Review of AI impact on the various stages of the global supply chain analysis
• Competitive landscape featuring strategic initiatives, market spendings and VC funding outlook

Report Scope

The number of cell and gene therapy (CGT) products approved by the U.S. Food and Drug Administration (FDA) has increased each year, driving up demand for CGT. The intricacy of CGT has proven difficult for conventional software systems to handle, despite advances in drug discovery and therapy development. Conventional software frequently lacks the intelligence and adaptability needed to manage the complexities of CGT. Cell and gene therapy-specific AI platforms can manage complex biological data. AI tools help manufacturers and scientists navigate the complexity of CGT more accurately and efficiently.